•  
  •  
 

The Thai Journal of Pharmaceutical Sciences

Abstract

Background: Drug therapy problems (DTPs) interfere with desired goals of therapy. This study evaluated DTPs in asthma identified during a pharmacist-led intervention in the asthma clinics of two Nigerian hospitals. Methods: This intervention study was conducted in the asthma clinics, University of Nigeria Teaching Hospital and Lagos University Teaching Hospital. Eligible participants were patients with asthma recruited into a pharmacist-led intervention study and followed up for 6 months. The Pharmaceutical Care Network Europe – Drug-related Problem Classification V6.2 in English (PCNE-DRP V6.2) was utilized to evaluate the DTPs. Results: Seventy-eight patients with asthma participated. A total of 158 DTPs were identified. Majority of the DTPs were manifest (96.2%). Salmeterol/Fluticasone (Seretide® Diskus®) was most implicated (43.7%). The most common type of DTP was patients not benefitting from the optimal effect of their drug treatment (63.9%). More than half of the causes were from drug under-used/administered (55.1%) or the patients unable to use the drug form as directed (60.1%). About three-quarter (76.6%) of the DTPs were totally solved. Conclusion: Drug use/administration process was the major cause of the DTPs. Patient counseling accounted for a bulk of the interventions. Pharmacists should be proactive in preventing, identifying, and resolving DTPs.

Publisher

Faculty of Pharmaceutical Sciences, Chulalongkorn University

First Page

229

Last Page

234

Download

Included in

Pharmacology Commons

Share

COinS